Affinity DataIC50: 12nMAssay Description:Modulation of capsid assembly in HBV assessed as inhibition of viral DNA replicationMore data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM supplemented wi...More data for this Ligand-Target Pair
Affinity DataIC50: 430nMAssay Description:Inhibition of HBV C150-Bodipy FL N-(2-aminoethyl) maleimide labeled capsid assessed as reduction in NaCl-induced capsid assembly preincubated for 15 ...More data for this Ligand-Target Pair
Affinity DataIC50: 710nMAssay Description:Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM supplemented wi...More data for this Ligand-Target Pair
Affinity DataIC50: 800nMAssay Description:Inhibition of HBV C150-Bodipy FL N-(2-aminoethyl) maleimide labeled capsid assessed as reduction in NaCl-induced capsid assembly preincubated for 15 ...More data for this Ligand-Target Pair
Affinity DataIC50: 840nMAssay Description:Inhibition of capsid protein in lamivudine/entecavir-resistant Hepatitis B virus harboring rtL180M/rtM204V/rt184L mutant infected in human HepG2.2.15...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of HBV C150-Bodipy FL N-(2-aminoethyl) maleimide labeled capsid assessed as reduction in NaCl-induced capsid assembly preincubated for 15 ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.54E+3nMAssay Description:Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM supplemented wi...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of HBV capsid assembly infected in human HepG2(2.2.15) cells assessed as inhibition of intracellular viral DNA level after 8 days by agaro...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of capsid protein in lamivudine/entecavir-resistant Hepatitis B virus harboring rtL180M/rtM204V/rt184L mutant infected in human HepG2.2.15...More data for this Ligand-Target Pair
Affinity DataIC50: 1.93E+3nMAssay Description:Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM supplemented wi...More data for this Ligand-Target Pair
Affinity DataIC50: 2.48E+3nMAssay Description:Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM supplemented wi...More data for this Ligand-Target Pair
Affinity DataIC50: 2.80E+3nMAssay Description:Modulation of capsid assembly in HBV assessed as inhibition of viral DNA replicationMore data for this Ligand-Target Pair
Affinity DataIC50: 2.81E+3nMAssay Description:Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM supplemented wi...More data for this Ligand-Target Pair
Affinity DataIC50: 4.07E+3nMAssay Description:Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM supplemented wi...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of capsid protein in lamivudine/entecavir-resistant Hepatitis B virus harboring rtL180M/rtM204V/rt184L mutant infected in human HepG2.2.15...More data for this Ligand-Target Pair
Affinity DataKd: 7.94E+4nMAssay Description:Binding affinity to HBcAgMore data for this Ligand-Target Pair
Affinity DataKd: 1.85E+4nMAssay Description:Binding affinity to HBcAgMore data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <1.00E+3nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <1.00E+3nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
TargetCapsid protein(Hepatitis B virus genotype C subtype ayr (isolate ...)
Novira Therapeutics
US Patent
Novira Therapeutics
US Patent
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
Affinity DataEC50: 12nMAssay Description:Inhibition of reverse transcriptase M204I/S202G double mutant expressing entecavir-resistant hepatitis B virus capsid assembly in human Huh7 cells as...More data for this Ligand-Target Pair
Affinity DataEC50: 83nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
Affinity DataEC50: 48nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
Affinity DataEC50: >1.64E+4nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
Affinity DataEC50: 42nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
Affinity DataEC50: 26nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
Affinity DataEC50: 100nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
Affinity DataEC50: 3.50E+3nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair
Affinity DataEC50: 200nMAssay Description:Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by...More data for this Ligand-Target Pair